Leiomyosarcomas are rare malignant tumors arising from smooth muscle cells and may develop in various anatomical locations. Laryngeal involvement is exceptionally rare, accounting for less than 1% of malignant laryngeal tumors, particularly in a post-radiotherapy context. We report the case of a 75-year-old patient treated in 2005 for an undifferentiated carcinoma of the nasopharynx with induction chemotherapy followed by concomitant chemoradiotherapy. Seventeen years after the initial treatment, the patient presented with chronic cervical pain associated with dysphonia. Nasofibroscopy and cervico-thoracic imaging revealed a supraglottic tumoral process. Histopathological examination combined with immunohistochemical analysis confirmed the diagnosis of laryngeal leiomyosarcoma. The patient underwent total laryngectomy followed by adjuvant radiotherapy at a dose of 60 Gy. A favorable clinical and radiological outcome was observed for two years, after which pulmonary recurrence occurred. Laryngeal leiomyosarcoma is an exceptionally rare entity, often associated with a poor prognosis. Its late occurrence after radiotherapy, as illustrated in our case, highlights the importance of prolonged clinical follow-up in irradiated patients.
References
[1]
Marioni, G., Staffieri, C., Marino, F. and Staffieri, A. (2005) Leiomyosarcoma of the Larynx: Critical Analysis of the Diagnostic Role Played by Immunohistochemistry. AmericanJournalofOtolaryngology, 26, 201-206. https://doi.org/10.1016/j.amjoto.2004.11.007
[2]
Dorobisz, K., Frączek, M., Kowalski, P. and Zatoński, T. (2020) Concurrent Squamous Cell Carcinoma and Leiomyosarcoma in the Larynx at Relapse 15 Years Post-radiation for Primary Laryngeal Cancer. Journal of College of Physicians and Surgeons Pakistan, 35, 871-873. https://doi.org/10.29271/jcpsp.2020.08.871
[3]
Abid, W., Yassine, Y., Mezri, S., Souissi, H., Khaireddine, N., Lachkham, A., Touati, S. and Gritli, S. (2013) Leomyosarcome du larynx. Journal Tunisiend’ORL et de ChirurgieCervico-Faciale, 26, 61–63. https://www.ajol.info/index.php/jtdorl/article/view/89311
[4]
Patel, K., French, C., Khariwala, S.S., Rohrer, M. and Kademani, D. (2013) Intraosseous Leiomyosarcoma of the Mandible: A Case Report. JournalofOralandMaxillofacialSurgery, 71, 1209-1216. https://doi.org/10.1016/j.joms.2013.01.028
[5]
Pfeiffer, J., Boedeker, C.C., Ridder, G.J., Maier, W. and Kayser, G. (2006) Radiation-induced Leiomyosarcoma of the Oropharynx. DiagnosticPathology, 1, Article No. 22. https://doi.org/10.1186/1746-1596-1-22
[6]
Marioni, G., Bertino, G., Mariuzzi, L., Bergamin-Bracale, A.M., Lombardo, M. and Beltrami, C.A. (2000) Laryngeal Leiomyosarcoma. The Journal of Laryngology & Otology, 114, 398-401. https://doi.org/10.1258/0022215001905698
[7]
Darouassi, Y., Bouaity, B., Zalagh, M., Rimani, M., Abrouq, A. and Azendour, B. (2005) Laryngeal leiomyosarcoma. B-ENT, 1, 145-149. https://pubmed.ncbi.nlm.nih.gov/16255499/
[8]
Judson, I., Verweij, J., Gelderblom, H., Hartmann, J.T., Schöffski, P., Blay, J., etal. (2014) Doxorubicin Alone versus Intensified Doxorubicin Plus Ifosfamide for First-Line Treatment of Advanced or Metastatic Soft-Tissue Sarcoma: A Randomised Controlled Phase 3 Trial. TheLancetOncology, 15, 415-423. https://doi.org/10.1016/s1470-2045(14)70063-4